BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20797567)

  • 1. Obesity and chronic kidney disease.
    Kopple JD
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S29-30. PubMed ID: 20797567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of obesity on chronic kidney disease.
    Kopple JD; Feroze U
    J Ren Nutr; 2011 Jan; 21(1):66-71. PubMed ID: 21195923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global burden of chronic kidney disease and the way forward.
    Alebiosu CO; Ayodele OE
    Ethn Dis; 2005; 15(3):418-23. PubMed ID: 16108301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obesity and chronic kidney disease].
    Bondar' IA; Klimontov VV; Simakova AI
    Ter Arkh; 2011; 83(6):66-70. PubMed ID: 21786579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and chronic kidney disease.
    Eknoyan G
    Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
    Brenner BM; Meyer TW; Hostetter TH
    N Engl J Med; 1982 Sep; 307(11):652-9. PubMed ID: 7050706
    [No Abstract]   [Full Text] [Related]  

  • 9. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of chronic renal disease.
    Klahr S
    Nutrition; 1990; 6(3):207-12. PubMed ID: 2135999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progression factors in chronic kidney disease. Non-immunological mechanisms].
    Fernández Fresnedo G; Sánchez Plumed J; Arias M; Del Castillo Caba D; López Oliva MO
    Nefrologia; 2009; 29 Suppl 1():16-24. PubMed ID: 19675657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hypertension and nephropathy.
    Rosario RF; Wesson DE
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):130-4. PubMed ID: 16481878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal disease in primary gout.
    Barlow KA; Beilin LJ
    Q J Med; 1968 Jan; 37(145):79-96. PubMed ID: 5657765
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital].
    Sumaili EK; Krzesinski JM; Cohen EP; Nseka NM
    Nephrol Ther; 2010 Jul; 6(4):232-9. PubMed ID: 20409770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive nephrosclerosis.
    Hill GS
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):266-70. PubMed ID: 18408477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis of CKD and its prevention.
    Amaresan MS; Geetha R
    J Assoc Physicians India; 2008 Jan; 56():41-6. PubMed ID: 18472500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines.
    Bianchi ME; Farías EF; Bolaño J; Massari PU
    Ren Fail; 2006; 28(8):665-70. PubMed ID: 17162424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.